Abstract:Author summaryS. au infection is a common and serious disease threatening humans and animals. Emerging evidence has supported the protective effects of the gut microbiota in regulating host susceptibility to pathogens. However, whether and how modulation of the gut microbiota by dietary components contributes to protection against pathogen invasion in distal organs remain unknown. Here, using an S. au-induced mouse mastitis model, we found that consumption of an HI-enriched diet alleviated S. au-induced mastitis in mice, and that this effect was dependent on the gut microbiota as the depletion of commensal microbiota reversed the protective effect of an HI-enriched diet. The role of the gut microbiota in HI diet-mediated effects was also confirmed by FMT. We further observed that treatment with an HI diet increased fecal SCFA levels, which can alleviate S. au-induced mastitis in mice by activating host antimicrobial programs in macrophages through inhibition of histone deacetylase 3. Our research indicates the important role of gut microbiota and its metabolism in protecting against S. au infection in distal organs and serves as a basis for other infectious diseases. Mounting evidence suggests that the gut microbiota plays an important role in the pathogenesis of mastitis, an important disease affecting the health of lactating women and the development of the dairy industry. However, the effect of the regulation of the gut microbiota by dietary components on mastitis development remains unknown. In this study, we found that a fiber-enriched diet alleviated Staphylococcus aureus (S. au)-induced mastitis in mice, which was dependent on the gut microbiota as depletion of the gut microbiota by antibiotics abolished this protective effect. Likewise, fecal microbiota transplantation (FMT) from high-inulin (HI)-treated mice (HIF) to recipient mice improved S. au-induced mastitis in mice. Consumption of an HI diet and HIF increased fecal short-chain fatty acid (SCFA) levels compared with the control group. Moreover, treatment with SCFAs, especially butyrate, alleviated S. au-induced mastitis in mice. Mechanistically, consumption of an HI diet enhanced the host antimicrobial program in macrophages through inhibiting histone deacetylase 3 by the production of butyrate. Collectively, our results suggest that modulation of the gut microbiota and its metabolism by dietary components is a potential strategy for mastitis intervention and serve as a basis for other infectious diseases.

Ginseng polysaccharides promote gut microbiota mediated deoxycholic acid to alleviate LPS-induced mastitis by regulating TGR5-cAMP-PKA-NF-κB/NLRP3 pathway

Gut microbiota-mediated secondary bile acid alleviates Staphylococcus aureus-induced mastitis through the TGR5-cAMP-PKA-NF-κB/NLRP3 pathways in mice

Polydatin Ameliorates Staphylococcus Aureus- Induced Mastitis in Mice Via Inhibiting TLR2- Mediated Activation of the P38 MAPK/NF-κB Pathway

Anti-inflammatory Mechanism of Ginsenoside Rg1: Proteomic Analysis of Milk from Goats with Mastitis Induced with Lipopolysaccharide

Fucoidan Protects Against LPS-induced Mastitis and Enhances the Integrity of Blood-Milk Barrier by Activating AMPK/Nrf2 and Autophagy

Protective Effects Of Lentinan Against Lipopolysaccharide-Induced Mastitis In Mice

A fiber-enriched diet alleviates Staphylococcus aureus-induced mastitis by activating the HDAC3-mediated antimicrobial program in macrophages via butyrate production in mice

Targeting Gut Microbiota As a Possible Therapy for Mastitis

Elevated muramyl dipeptide by sialic acid-facilitated postantibiotic pathobiont expansion contributes to gut dysbiosis-induced mastitis in mice

Gambogic acid alleviates inflammation and apoptosis and protects the blood-milk barrier in mastitis induced by LPS

Gut dysbiosis induces the development of mastitis through a reduction in host anti-inflammatory enzyme activity by endotoxemia

A fiber-enriched diet alleviates <i>Staphylococcus aureus</i>-induced mastitis by activating the HDAC3-mediated antimicrobial program in macrophages via butyrate production in mice

Gardenoside attenuates Staphylococcus aureus-induced mastitis by inhibiting inflammation and ferroptosis through Nrf2/SLC7A11/GPX4 signaling pathway

Astragalin Suppresses Inflammatory Responses Via Down-Regulation of NF-κB Signaling Pathway in Lipopolysaccharide-Induced Mastitis in a Murine Model

Effect of Subcutaneous Injection of Ginseng on Cows with Subclinical Staphylococcus Aureus Mastitis.

The Gut Microbiota Contributes to the Development of Staphylococcus Aureus-Induced Mastitis in Mice.

Therapeutic effect of ginsenoside Rg1 on mastitis experimentally induced by lipopolysaccharide in lactating goats.

CGA alleviates LPS-induced inflammation and milk fat reduction in BMECs through the NF-κB signaling pathway

Protective Effect of Chlorogenic Acid on Lipopolysaccharide-Induced Inflammatory Response in Dairy Mammary Epithelial Cells.

Mammary Γδ T Cells Promote IL-17A-mediated Immunity Against Staphylococcus Aureus-Induced Mastitis in a Microbiota-Dependent Manner

GPR109A alleviate mastitis and enhances the blood milk barrier by activating AMPK/Nrf2 and autophagy